Pulmonx Corp — Investor Relations & Filings

Pulmonx Corp. is a medical technology company specializing in interventional pulmonology and minimally invasive treatments for severe obstructive lung diseases. The company's core offering is the Zephyr Endobronchial Valve, a non-surgical treatment for patients with severe emphysema, a form of Chronic Obstructive Pulmonary Disease (COPD). The Zephyr Valve is a small, one-way valve implanted in the airways via a bronchoscopic procedure. It is designed to reduce hyperinflation (trapped air) in diseased parts of the lung, alleviating a primary cause of breathlessness. This one-time procedure is clinically proven to improve lung function, exercise capacity, and quality of life. Pulmonx also provides diagnostic and planning tools to support physicians in patient selection and treatment.